CORRECTION article

Front. Neurol., 10 April 2025

Sec. Headache and Neurogenic Pain

Volume 16 - 2025 | https://doi.org/10.3389/fneur.2025.1577914

Corrigendum: Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults

    AR

    Adarsh Raja 1

    RA

    Rabia Asim 1

    MH

    Muhammad Hamza Shuja 2

    SR

    Sandesh Raja 2

    TS

    Tazheen Saleh Muhammad 1

    SB

    Simran Bajaj 3

    AH

    Abdul Hadi Ansari 1

    HA

    Hamza Ali 1

    IA

    Iffat Ambreen Magsi 1

    MH

    Muhammad Hammad Faridi 1

    HA

    Hamza Ali Hasnain Sheikh 1

    MJ

    Muhammad Junaid Imran 1

    MA

    Muhammad Ahmed 1

    MS

    Muhammad Sohaib Asghar 4,5*

  • 1. Department of Internal Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan

  • 2. Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan

  • 3. Department of Internal Medicine, Shaheed Mohtarma Benazir Bhutto University, Larkana, Pakistan

  • 4. Department of Internal Medicine, AdventHealth, Sebring, FL, United States

  • 5. Department of Internal Medicine, Mayo Clinic, Rochester, MN, United States

Article metrics

View details

1,3k

Views

347

Downloads

In the published article, there was an error. Two reviewer comments inadvertently appeared in the final published article. Two sentences have been removed from the Results section, Secondary outcomes. These sentences previously stated:

Regarding change in monthly headache days, I do not see the relevance to do a sensitivity analysis. Also after excluding Ailani et al., the mean value with 95% CI does not appear so different than the previous one.

A sentence has been removed from the Results section, Meta-regression, first paragraph. This sentence previously stated:

The meta-regression is not anticipated in the statistical analysis plan. What is the purpose of such analysis?

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

atogepant, CGRP, migraine, headache, meta-analysis

Citation

Raja A, Asim R, Shuja MH, Raja S, Muhammad TS, Bajaj S, Ansari AH, Ali H, Magsi IA, Faridi MH, Sheikh HAH, Imran MJ, Ahmed M and Asghar MS (2025) Corrigendum: Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults. Front. Neurol. 16:1577914. doi: 10.3389/fneur.2025.1577914

Received

16 February 2025

Accepted

25 February 2025

Published

10 April 2025

Volume

16 - 2025

Edited and reviewed by

Massimiliano Valeriani, University of Rome Tor Vergata, Italy

Updates

Copyright

*Correspondence: Muhammad Sohaib Asghar

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics